Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H34O15 |
| Molecular Weight | 550.5071 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 13 / 13 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)[C@H]4[C@@H]1CC=C4CO
InChI
InChIKey=FYZYXYLPBWLLGI-AUOPOVQUSA-N
InChI=1S/C23H34O15/c1-33-20(32)10-6-34-21(13-8(4-24)2-3-9(10)13)38-23-19(31)17(29)15(27)12(37-23)7-35-22-18(30)16(28)14(26)11(5-25)36-22/h2,6,9,11-19,21-31H,3-5,7H2,1H3/t9-,11-,12-,13-,14-,15-,16+,17+,18-,19-,21+,22-,23+/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/27302600Curator's Comment: Description was created based on several sources, including http://www.journal.csj.jp/doi/10.1246/cl.150172
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27302600
Curator's Comment: Description was created based on several sources, including http://www.journal.csj.jp/doi/10.1246/cl.150172
Genipin 1-beta-gentiobioside, an iridoid glucoside, is one of the major components in gardenia fruit (“Zhizi” in Chinese) that constitutes several edible pigments. Genipin 1-beta-gentiobioside is also widely applied in many classical compound prescriptions for thousand years in Asia, such as Zhizi-Dahuang decoction for reducing icterus and relaxing bowels, Zhizi-Chi decoction for depression treatment, and Yinchen-Hao decoction for the therapies on jaundice with damp-heat pathogen. As one of the major pharmacodynamic substances, Genipin 1-beta-gentiobioside has valuable biological activities, such as resisting heart failure induced by pentobarbital sodium through enhancing heart inotropy and lowering the preload of heart; attenuating melanogenesis, and releasing cytotoxicities. Moreover, Genipin 1-beta-gentiobioside is also a promising candidate for the treatment of memory dysfunction because of its excellent anti-acetylcholine activity in vitro and antiamnesic effect via increasing the acetylcholine levels in brain.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL220 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27302600 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Rapid profiling and target analysis of principal components in Fuling Decoctions by UFLC-DAD-ESI-MS. | 2010-09 |
|
| Determination of geniposide, gardenoside, geniposidic acid and genipin-1-beta-gentiobioside in Gardenia jasminoides by high-performance liquid chromatography. | 1988-11-25 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27302600
Oral dose (150 mg/kg, dissolved in saline)
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27302600
Genipin 1-beta-gentiobioside exerted outstanding anti-AChE activity (60.23%), at a final concentration of 25 ug/mL
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3082301
Created by
admin on Mon Mar 31 23:03:32 GMT 2025 , Edited by admin on Mon Mar 31 23:03:32 GMT 2025
|
PRIMARY | |||
|
DTXSID50183554
Created by
admin on Mon Mar 31 23:03:32 GMT 2025 , Edited by admin on Mon Mar 31 23:03:32 GMT 2025
|
PRIMARY | |||
|
0NI5399RDZ
Created by
admin on Mon Mar 31 23:03:32 GMT 2025 , Edited by admin on Mon Mar 31 23:03:32 GMT 2025
|
PRIMARY | |||
|
29307-60-6
Created by
admin on Mon Mar 31 23:03:32 GMT 2025 , Edited by admin on Mon Mar 31 23:03:32 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD